Daniel Sheinson
Daniel Sheinson
Statistical Researcher at Genentech, Inc.; PhD from University of California, Santa Barbara
Verified email at pstat.ucsb.edu
Title
Cited by
Cited by
Year
TGFâ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ...
Nature 554 (7693), 544-548, 2018
7072018
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
WR Proctor, AJ Foster, J Vogt, C Summers, B Middleton, MA Pilling, ...
Archives of toxicology 91 (8), 2849-2863, 2017
1082017
Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model
JM McBride, JJ Lim, T Burgess, R Deng, MA Derby, M Maia, P Horn, ...
Antimicrobial agents and chemotherapy 61 (11), 2017
302017
Comparison of the performance of particle filter algorithms applied to tracking of a disease epidemic
DM Sheinson, J Niemi, W Meiring
Mathematical biosciences 255, 21-32, 2014
272014
In vitro assessment of chemotherapy-induced neuronal toxicity
C Snyder, L Yu, T Ngo, D Sheinson, Y Zhu, M Tseng, D Misner, K Staflin
Toxicology in vitro 50, 109-123, 2018
132018
Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive donor and CMV-seronegative solid organ transplant recipients
JM McBride, D Sheinson, J Jiang, N Lewin-Koh, BG Werner, JKL Chow, ...
Open forum infectious diseases 6 (2), ofz003, 2019
102019
Safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza a challenge model: A phase 2 randomized trial
JM McBride, JJ Lim, T Burgess, R Deng, MA Derby, M Maia, P Horn, ...
Antimicrobial Agents and Chemotherapy, 2017
5*2017
Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non–Small-Cell Lung Cancer
JT Cohen, PJ Lin, DM Sheinson, WB Wong, N Wu, YM Yim, SD Ramsey
Journal of Oncology Practice 15 (11), e948-e956, 2019
42019
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection
GK Rao, RA Prell, ST Laing, SCM Burleson, A Nguyen, JM McBride, ...
Toxicological Sciences 169 (2), 409-421, 2019
22019
HER2-Positive Metastatic Breast Cancer: A Retrospective Cohort Study of Healthcare Costs in the Targeted-Therapy Age
JA Sussell, D Sheinson, N Wu, B Shah-Manek, A Seetasith
Advances in Therapy, 1-14, 2020
12020
Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer
D Sheinson, WB Wong, N Wu, AS Mansfield
Lung Cancer, 2020
12020
Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor Outflow
EA Thackaberry, Y Zhou, CLZ de Zafra, G Fuh, CV Lee, S Sanowar, ...
Investigative Ophthalmology & Visual Science 60 (13), 4097-4108, 2019
12019
Variance component analysis of circulating miR-122 in serum from healthy human volunteers
J Vogt, D Sheinson, P Katavolos, H Irimagawa, M Tseng, KR Alatsis, ...
PloS one 14 (7), e0220406, 2019
12019
Identifying Patients With Neuromyelitis Optica Spectrum Disorder in US Insurance Claims Databases From 2001 to 2017
A Exuzides, W Ning, D Sheinson, C Costantino, P Sidiropoulos, ...
MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 104-105, 2020
2020
PND83 IDENTIFYING NEUROMYELITIS OPTICA PATIENTS FROM INSURANCE CLAIMS DATA USING NFERX, A NATURAL LANGUAGE PROCESSING-BASED PLATFORM
E Garcia-Rivera, J Park, Z Doctor, A Lopez-Marquez, D Sheinson, ...
Value in Health 23, S275, 2020
2020
PND41 ESTIMATING THE COSTS OF EMERGENCY ROOM VISITS AND INPATIENT HOSPITALIZATIONS IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDER IN THE UNITED STATES FROM COMMERCIAL …
A Exuzides, D Sheinson, P Sidiropoulos, A Surinach, L Cook, C Meyer, ...
Value in Health 23, S266, 2020
2020
PCN24 DOES LONGER TREATMENT PERSISTENCE IN THE REAL-WORLD TRANSLATE TO BETTER CLINICAL OUTCOMES? A CASE STUDY OF ALK+ NON-SMALL CELL LUNG CANCER (NSCLC)
D Sheinson, N Wu, A Seetasith, W Wong
Value in Health 23, S26, 2020
2020
PCN276 PREDICTING MORTALITY IN CLAIMS DATA AMONG PATIENTS WITH ADVANCED COLORECTAL CANCER
WJ Wang, CS Meyer, N Wu, D Sheinson
Value in Health 23, S72, 2020
2020
Real-world outcomes with ocrelizumab compared with other disease-modifying therapies in US commercial claims databases (2911)
NJ Engmann, D Sheinson, E Yang, D Fiore, E Alvarez, KV Nair, ...
Neurology 94 (15 Supplement), 2020
2020
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection
GK Rao, RA Prell, ST Laing, SCM Burleson, A Nguyen, JM McBride, ...
INTERNATIONAL JOURNAL OF TOXICOLOGY 39 (1), 73-74, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20